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ABSTRACTSAims: Of all breast lumps in young women, very few are malignant. Some
patients may not require all elements of triple assessment including those
with clearly identiﬁed benign conditions with no other suspicious features
identiﬁed clinically and radiologically. Aim of this study was to see if
biopsy of clinically and radiologically benign breast lumps of women under
30 years is necessary.
Methods: Retrospective study of women under 30 years presenting with
breast symptoms between December 2000 to January 2010.
Results: There were 864 patients. 612 had FNA and 252 CB. 544 met the
inclusion criteria. There were 496 (U2), 39 (U3) and 9 (U3+) on ultrasonog-
raphy. Of the 496 U2, 495 patients pathology was benign (B1/B2). All U3
patient's pathologywasbenign.AllU3+patientspathologyconﬁrmedcancer.
9 cases of U4/5 all conﬁrmed cancer on pathology.1 U2was reported as a C4.
Conclusions: 495 clinically and radiologically benign cases were proven to
have benign disease on FNA/CB. If there is a discrepancy between clinical
and radiological ﬁndings there should be a low threshold for biopsy.
Otherwise it may be safe to opt out of needle biopsy as it avoids unnec-
essary morbidity and use of precious resources.
0106: A RETROSPECTIVE STUDY OF AXILLARY LYMPH NODE CLEARANCE
FOR PATIENTS DIAGNOSED WITH EARLY BREAST CANCER AND
AXILLARY LYMPH NODE INVOLVEMENT
Suet May Chan 2, Vivien Ng 1, Stephen Courtney 1, Brendon Smith 1, Hilary
Umeh 1, Pankaj Roy 2. 1Royal Berkshire Hospital, Reading, Berkshire, UK;
2 John Radcliffe Hospital, Oxford, Oxfordshire, UK
Aim: Axillary nodal status is the most important prognostic indicator that
inﬂuences adjuvant therapy. Sentinel lymph node biopsy (SLNB) is the
standard procedure performed to stage the axilla. The current standard is
to perform axillary node clearance (ANC) if there is evidence of lymph node
(LN) metastases. This study aims to assess the number of positive LN on
ANC following a positive SLNB or biopsy on clinical/ultrasound assessment.
Methods: Patients with ANC (January 2008 to December 2009) were
identiﬁed along with LN yields on SLNB and ANC. Clinical-pathological
parameters and treatment details were also collected. ANC was performed
for three groups: SLNB + micrometastasis, SLNB + macrometastasis and
positive axillary LN on clinical/ultrasound-guided biopsy.
Results: 170 ANC were performed in the two-year period. More than 40%
of patients with macrometastasis on SLNB had further positive LN on ANC.
Only 8% of patients with micrometastasis were found to have residual
axillary disease (p<0.001, Fisher's exact test). Completion ANC did not
provide any additional information to alter adjuvant treatment in patients
with micrometastasis.
Conclusion: The limited role of completion ANC in patients with SLNB +
micrometastasis is highlighted and therefore is likely to have an impact on
management of early breast cancer.
0112: FIVE YEARS AFTER INTRODUCTION, HAVE STANDARDISED
REFERRAL FORMS REDUCED THE NUMBER OF INAPPROPRIATE
REFERRALS TO BREAST CLINIC?
Valentina Lefemine, Gary Osborn, Anne marie Mainwaring, Sumit
Goyal. Breast Centre, Cardiff, UK
Introduction: In August 2005 new referral guidelines and updated referral
forms were issued to GP's in Cardiff with the aim of reducing unnecessary
referrals to breast clinic. An audit of 203 referral letters showed that 53% of
patients were referred using the new style form. 55% of referrals were
deemed inappropriate. After ﬁve years we aim to assess the impact of
standardised referral forms on inappropriate referrals to breast clinic.
Methods: A prospective audit of GP referrals to the breast clinic in June and
July 2010 was performed.
Results: 145 patients were included. 75% of patients were referred using
the referral forms but 58% of these were ﬁlled incompletely. Concordance
between GP and consultant ﬁndings was similar for written and form
referrals (65% for breast lumps, 54% and 59% for pain and 100% and 57% for
discharge respectively). Overall 8% referrals were deemed inappropriate
using national guidelines, of which 7 (6%) used the standardised form and
5 (14%) were letters. All patients referred inappropriately had a normal
diagnosis, none required a biopsy and all were discharged from clinic.
Conclusion: After ﬁve years, the majority of referrals to the breast clinic
are made using the standard referral form. The number of inappropriate
referrals has fallen to 8%.0113: MASTALGIA – ARE WE CARING IN THE COMMUNITY?
Valentina Lefemine, Julie Cornish, Elle Javad, Walid Abou-Samra. Glan
clwyd Hospital, Rhyl, UK
Introduction: Referral guidelines for mastalgia are well published. Breast
pain with no other clinical concern should be managed initially in
a primary care setting. Our aim was to look into the management of
mastalgia in the community and have an understanding on whether
guidelines are followed.
Method: A questionnaire was posted to all GP surgeries that referred to
our institution.
Results: 41 responses were received (34% response rate). 95% percent of
GPs consulted 1-5 women with mastalgia every month. 24% of GPs were
aware of referral guidelines for patients presenting with breast pain. 37% of
GPs refer a patient with mastalgia to the breast clinic at their ﬁrst
presentation, mostly as ‘urgent' or ‘soon' referrals. All respondent GPs
would initiate some form of management for mastalgia.
Conclusion: Mastalgia is the commonest breast symptom presenting to
general practitioners. Ignorance of national guidelines and fear of missing
a breast cancer results in a large number of patients being referred to the
breast clinic with signiﬁcant resource implications. GPs should be
encouraged to manage mastalgia in the community. We would advice
breast specialists to assume a primary role in promoting knowledge and
reassurance amongst GPs by means of leaﬂets, forums and meetings.
0132: PHYLLOIDES TUMOURS OF THE BREAST: A SINGLE CENTRE
EXPERIENCE
Valentina Lefemine, Gary Osborn, Verity Oloroso, Carrie Champ, Kate
Gower-Thomas, Rhodri Williams, Eiﬁon Vaughan-Williams. Royal
Glamorgan Hospital, Llantrisant, UK
Aims: Phylloides tumours (PT) are the most common non epithelial
neoplasms of the breast and account for 1% of all breast tumours. We aim
to report our experience on the management of PT over an eight year
period.
Methods: A retrospective review of all patients diagnosed with PT in
a single unit between January 2003 and December 2010 was performed.
Results: 31 patients were included. 27 patients had symptomatic and 4
patients screen detected lesions. Diagnostic imaging showed benign
features in 13 patients, equivocal features in 9 patients and features in
keeping with PT in 9 patients. All lesions were biopsied but a preoperative
diagnosis of PT was achieved in only 10 patients. 4 patients underwent
mastectomy,27 patients had a wide local excision. Final histology revealed
23 benign and 8 malignant PT. All patients were followed up for 12
months; we had a 9.6% recurrence rate, mostly in patients with benign
phylloides.
Conclusions: PT of the breast are a diagnostic challenge. There is a lack of
consensus on how to best manage these rare tumours and we would
recommend a low threshold for excising rapidly growing or large
supposedly benign lesions. All patients should be followed up as even
benign phylloides can reoccur.
0176: BREAST CANCER IN SYMPTOMATIC PATIENTS WHO HAVE
NORMAL USS AND/OR MAMMOGRAM
Andrew Mishreki, Syed Yousuf, Ranya Bafadal, Catherine
Chikerema. University Hospital North Durham, Durham, UK
Aim: There is no data published on the incidence of patients who present
to the breast clinic (with either a lump or thickening) and have normal
ﬁndings on USS and/or mammogram, however subsequently have biopsy
proven cancers.
The aim of our study was to determine this number in our centre.
Method: We called all of the patient's notes who were diagnosed with
breast cancer between 1st April 2009 and 31st October 2011 in our trust.
We retrospectively reviewed all presenting complaints, radiology and
histology ﬁndings, and multi-disciplinary team meeting decisions.
Results: In total we found 319 patients who were diagnosed with breast
cancer during this period.
Out of these 17 had normal imaging initially, however had histologically
conﬁrmed breast cancer/in-situ cancer on FNAC/core biopsy of the
symptomatic area.
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ABSTRACTSConclusions: Our study has shown that patients who present with
thickening or lumpiness of the breast should all have FNAC or core biopsy
of the symptomatic area, even in the presence of normal USS and/or
mammography.
This highlight's the importance of a thorough triple assessment in all
patients presenting to the breast clinic.
0236: IS THE BENEFIT OF INTRAOPERATIVE SENTINEL LYMPH NODE
BIOPSY (SLNB) ANALYSIS USING ONE-STEP NUCLEIC-ACID
AMPLIFICATION (OSNA) NEGATED BY THE NEED FOR FURTHER
BREAST SURGERY?
Dionysios D. Remoundos 1, Hannah A. Wilson 1, Farid Ahmed 1, Yoon
Chia 2, Giles H. Cunnick 1. 1Department of General Surgery, Wycombe
General Hospital, High Wycombe, UK; 2Department of Histopathology,
Wycombe General Hospital, High Wycombe, UK
SLNB is standard practice for axillary staging in clinically node-negative
breast cancer patients. Traditionally, SLNB-positive patients required
delayed axillary lymph node clearance (ALNC). The development of intra-
operative analysismethods, such asOSNA, hasmade single-stage procedures
possible.However, some argue that their beneﬁtmay benegatedby theneed
for further breast surgery. We aimed to assess the beneﬁt of intraoperative
OSNA compared to conventional SLNB analysis and delayed ALNC.
400 consecutive patients with clinically and radiologically normal axillary
lymph nodes, who underwent mastectomy or breast-conserving surgery
for invasive cancer or multifocal DICS, in a single institution fromMay 2010
to November 2011, were included. Routine localisation and intra-operative
OSNA analysis were performed. Patients positive for metastasis proceeded
to ALNC at the same setting. Those requiring additional breast procedures
were identiﬁed.
142 patients underwent an immediate ALNC. 14.6% of patients required re-
excision breast surgery. Only 21.4% of OSNA-positive patients required
further surgery.
Despite the need for re-excision breast surgery in cases of positive
margins, intra-operative OSNA analysis reduces the number of patients
requiring further surgery by 78.6%. Offering a single operation is better for
patients and the health economy, reducing waiting times and expediting
the start of adjuvant treatments.
0306: ULTRASOUND EVALUATION OF BREAST CANCER DEPTH. DOES
THIS PREDICT THE LIKELIHOOD OF SUPERFICIAL MARGIN
INVOLVEMENT?
Lulu Tanno, Catherine Boffa, Gavin Royle, Rachel Oeppen, Ramsey
Cutress. Southampton University Hospital Trust, Southampton, UK
Aim: We determined superﬁcial margin involvement (SMI) in patients
undergoing breast conserving surgery (BCS) and assessed if ultrasound
tumour depth predicts the likelihood of SMI.
Methods: A retrospective review of 201 BCS procedures undertaken in
2009. US report and images were used to determine the superﬁcial depth
of tumours.
Results: Tumour was present at one or more margin (including deep or
superﬁcial) in 41 (20%) cases and led to further surgery in 15 cases. A skin
ellipse was excised in 76 (38%), and of these, no specimens had isolated
SMI. In 2 cases skin involvement was clinically apparent pre-operatively.
From those without skin resection the superﬁcial margin was the only
margin involved in 4 cases. In total there were 2 re-excisions for isolated
superﬁcial margins, one following a skin ellipse and the other following no
skin resection. The mean USS depth of the tumour in cases with SMI was
4mm whilst the mean depth of those without SMI was 10mm (p¼0.002).
Conclusions: Isolated SMI is rare following BCS. US depth may be a good
indicator of SMI. If USS depth is <5mm an ellipse of skin overlying the
cancer should be considered rather than excision from a distant site.
0307: INTRA-OPERATIVE ULTRASOUND IS AN EFFECTIVE TECHNIQUE
FOR EXCISION OF EARLY BREAST CANCER
Jennifer Pollard, S. Pathak, Anu Shrotri, C.D. Parmar, Lee Martin. University
Hospitals Aintree, Liverpool, UK
Introduction: Radio-guided occult lesion localisation (ROLL) has been
used to excise impalpable breast lesions instead of wire-guided local-
isation. We hypothesise Intra-operative Ultrasound Marking (IUM) is aseffective as ROLL for excision of ultrasound-detectable lesions and more
cost-effective.
Methods: Retrospective analysis performed on consecutive patients
undergoing IUM WLE over 3 years. Baseline demographics, tumour size,
margin clearance, histology and further procedures performed were
analysed.
Results: Sixty-six IUM WLE's were performed June 2008-November 2011
for non-palpable lesions, with 100% success rate for excision. Mean patient
age 58-years (27-81 years). Mean radiological tumour size 13.5mm (4.5-
28.4mm), mean invasive tumour size 18.7mm (3-77mm) and mean spec-
imen weight 43.9 grams. 63 patients (95.3%) had clear radial margins
(mean clearance 3.35mm, range 1.1-7mm). Three patients (4.7%) had
positive margins for invasive malignancy. These results compare favour-
ably with ROLL data.
Conclusions: Our results demonstrate no malignant lesions were
missed; therefore this procedure can be safely used to excise early,
impalpable screen-detected breast cancers. It improves peri-operative
patient journey; increases patient safety and convenience, whilst
making savings in cost of nuclear medicine services. Furthermore, it can
be performed in hospitals without a nuclear medicine department. Our
recommendations are breast surgeons will need to undergo training in
ultra-sound scanning.
0318: MEDICAL ASTROLOGY: DEBUNKING THE MYTH FOR BREAST
DISEASE
Thomas Micic, Rachel Barnes, Kelvin Gomez. Aneurin Bevan Health Board
Trust, Abergavenny, South Wales, UK
Introduction: Medical astrology predicts that disease is under the inﬂu-
ence of astrological signs. Being born within the zodiac sign of Cancer is
meant to increase your chances of developing diseases of the breast.
Methods: A retrospective cohort of 1458 patients who presented with
breast disease was derived from hospital admission data from a single
Health Board from January 2008 to February 2011. Statistical conﬁrmation
of the dataset was performed using the Chi-Squared test.
Results: Results showed that the probability of developing benign breast
disease and being born within the zodiac sign of Cancer was 7.83% (Range
6.01-10.97% for the other zodiac signs); pre-invasivemalignancy was 8.76%
(Range 5.84-11.68% for the other zodiac signs); and for malignant disease
was 9.25% (Range 7.71-9.91% for the other zodiac signs). There was no
statistically signiﬁcant difference between the Zodiac groups.
Conclusions: The basis for medical astrology, as with astrology itself, is
rooted in superstition and pseudoscience. Unfortunately, a proportion of
patients presenting with breast disease still seek advice from medical
astrologers, who may inﬂuence their treatment options. Our results show
that there is no statistical difference. The authors hope that by debunking
this myth, fewer patients will be adversely affected by inappropriate
advice.
0345: SAME DAY ADMISSIONS ARE KEY TO SAVING MONEY IN ELECTIVE
BREAST SURGERY
Usman Khalid, Nicola Woodcock, Pawel Pietrzak, Sumit Goyal. The Cardiff
and Vale Breast Centre, Cardiff, Wales, UK
Aim: To evaluate our length of stay for Elective Breast Surgery and explore
ways to increase our rate of Same Day Admissions (SDA's) and reduce
costs.
Method: Retrospective data on admission, discharge and day of surgery
were collected for all patients who underwent Breast Surgery at Cardiff
Breast Centre between April 2010 and March 2011.
Results: 626 patients underwent Breast Surgery, with a median age of
57 and average length of stay 3 days. 28% of patients were admitted on
day of surgery (62% of which day-cases), 71% day before surgery and 1%
more than 1 day before surgery. Reasons for admission day before
surgery were: Sentinel Node Radioisotope(RI) injection(50%), Wire
insertion(6%), ‘Normal Culture' within this trust for pre-operative
assessment(44%).
Conclusions: Based on a £200 cost per bed day, we estimated that our
Trust could save £89,000 per year if all patients arrived on day of surgery.
Ways to increase our SDA rate include: 1. RI injection day before surgery
and admission on day of surgery; 2. Setup of a pre-assessment clinic -
Clinic space, nursing staff and junior doctors are already set in place for this
